You are here

Article Text

Article menu
Download PDFPDF
Ear, nose and throat
Lipochoristoma: a rare cause of unilateral hearing loss
  1. Krupali Brahmbhatt1,
  2. Sreemathi Harieaswar2 and
  3. Sudip Das3
  1. 1Clinical Education, University Hospitals of Leicester NHS Trust, Leicester, UK
  2. 2Radiology, University Hospitals of Leicester NHS Trust, Leicester, UK
  3. 3Otorhinolaryngology, Leicester Royal Infirmary, Leicester, UK
  1. Correspondence to Dr Krupali Brahmbhatt; k.brahmbhatt{at}nhs.net

Abstract

We present our single-centre experience of two cases of lipochoristoma, a rare lesion causing unilateral hearing loss. Differential diagnoses include the more common vestibular schwannoma, haemangioma and meningioma. Diagnosis was confirmed with fat suppression sequences on MRI. Management of both patients was with serial imaging, under the guidance of neuro-otology multidisciplinary team, due to the slow and typically non-aggressive progression of this lesion.

  • Ear, nose and throat/otolaryngology
  • Radiology

https://doi.org/10.1136/bcr-2023-259086

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors The following authors were responsible for drafting of the text, sourcing and editing of clinical images, investigation results, drawing original diagrams and algorithms, and critical revision for important intellectual content: KB and SH. The following authors gave final approval of the manuscript: SD and SH.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.